SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-227645
Filing Date
2017-07-13
Accepted
2017-07-13 17:01:03
Documents
1
Group Members
EXCEL MEDICAL VENTURES, LLCFREDERICK R. BLUMEJUAN ENRIQUEZSTEVEN R. GULLANS

Document Format Files

Seq Description Document Type Size
1 SC 13D d416401dsc13d.htm SC 13D 131628
  Complete submission text file 0001193125-17-227645.txt   133232
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90032 | Film No.: 17964007
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON STREET SUITE 2825 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 2825 BOSTON MA 02199 617-450-9800
EXCEL MEDICAL FUND LP (Filed by) CIK: 0001428044 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D